Related Experiment Videos
Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer
J R Spires1, M R Schwartz, R H Miller
1Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, TX 77030.
Archives of Otolaryngology--Head & Neck Surgery
|January 1, 1988
Summary
Anaplastic thyroid carcinoma (ATC) often arises from well-differentiated thyroid cancer. Despite aggressive treatments like surgery and chemotherapy, ATC has a poor prognosis, with a median survival of only four months.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Anaplastic thyroid carcinoma (ATC) is a rare but aggressive form of thyroid cancer.
- Understanding the origins and progression of ATC is crucial for improving patient outcomes.
Purpose of the Study:
- To review cases of anaplastic thyroid carcinoma treated at Baylor College of Medicine.
- To investigate the relationship between ATC and well-differentiated thyroid carcinoma.
- To evaluate the effectiveness of current treatment modalities and patient prognosis.
Main Methods:
- Retrospective review of fourteen anaplastic thyroid carcinoma cases.
- Analysis of patient demographics, tumor characteristics, treatment regimens, and survival data.
Main Results:
- A female preponderance (1.3:1) and median patient age of 62 years were observed.
- 71% of anaplastic tumors were associated with pre-existing or concurrent well-differentiated thyroid carcinoma.
- Median survival was four months, with only 21% of patients surviving one year.
Conclusions:
- Findings support the theory that ATC frequently transforms from well-differentiated thyroid carcinoma.
- Aggressive multimodal therapy (surgery, radiation, chemotherapy) offers a poor prognosis for ATC patients.
- Further research is needed to identify more effective therapeutic strategies for anaplastic thyroid carcinoma.